Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1243-1249

  Von Schweinitz, D ^a   Byrd, D J ^a   Hecker, H ^a   Weinel, P ^a   Bode, U ^b   Burger D ^a   Erttmann, R ^b   Harms, D ^b   Mildenberger, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Chemotherapy; Hepatoblastoma; Histology; Late sequelae; Surgery; Toxicity

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ARTICLE; CANCER SURVIVAL; CHILD; FEMALE; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; KIDNEY DISEASE; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SECOND LOOK SURGERY; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HEPATOBLASTOMA; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; TREATMENT OUTCOME;

EID: 0030740813     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00095-6     Document Type: Article

References (32)

1. Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood. A report of 47 cases. Cancer 1967, 20, 396-422.
2. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section survey - 1974. J Pediatr Surg 1975, 10, 329-337.
3. Evans AE, Land VA, Newton WA, Randolph GG, Sather HN, Teft M. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982, 50, 821-826.
4. Shafford EA, Pritchard J. Hepatoblastoma - a bit of a success story? Eur J Cancer 1994, 30A, 1050-1051.
5. Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 1991, 9, 2167-2176.
6. Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Paediatric Oncology Group study. J Clin Oncol 1993, 11, 96-99.
7. Andrassy RJ, Brennan LP, Siegel MM, et al. Preoperative chemotherapy for hepatoblastoma in children: report of six cases. J Pediatr Surg 1980, 15, 517-522.
8. Mahour GH, Wogu GU, Siegel SE, Isaacs H. Improved survival in infants and children with primary malignant liver tumors. Am J Surg 1983, 146, 236-240.
9. Weinblatt ME, Siegel SE, Siegel MM, Stanley P, Weitzmann JJ. Preoperative chemotherapy for unresectable primary hepatic malignancies in children. Cancer 1982, 50, 1061-1064.
10. Gauthier F, Valayer J, Le Thai B, Sinico M, Kalifa C. Hepatoblastoma and hepatocarcinoma in children: analysis of 29 cases. J Pediatr Surg 1986, 21, 424-429.
11. Mildenberger H, Bürger D, Weinel P. Hepatoblastoma: a retrospective study and proposal of a treatment protocol. Z Kinderchir 1989, 44, 78-82.
12. von Schweinitz D, Hecker H, Harms D, et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 1995, 30, 845-852.
13. Rossi R, Danzebrink S, Hillebrand D, Linnenbürger K, Ullrich K, Jürgens H. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994, 22, 27-32.
14. WHO. WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48. WHO Geneva, 1979.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
16. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, 1980.
17. Wu JT, Book L, Sudar K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res 1981, 15, 50-52.
18. von Schweinitz D, Wischmeyer P, Leuschner I, et al. Clinicopathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 1994, 30A, 1052-1058.
19. Quinn JJ, Altman AJ, Robinson HT, Cooke RW, Hight DW, Foster JH. Adriamycin and cisplatin for hepatoblastoma. Cancer 1985, 56, 1926-1929.
20. King DR, Ortega J, Campbell J, et al. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy. J Pediatr Surg 1991, 26, 1074-1081.
21. Reynolds M, Douglass EC, Finegold M, Cantor A, Glicksman A. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992, 27, 1080-1084.
22. Plaschkes J, Perilongo G, Shafford E, et al. SIOP trial report -overall preliminary results of SIOPEL-1 for treatment of hepatoblastoma (HB) with pre-operative chemotherapy - continuous infusion cisplatin and doxorubicin (PLADO). Med Pediatr Oncol 1994, 23, 170 (Abstr 0-4).
23. Ortega JA, Douglass E, Feusner J, et al. Treatment of hepatoblastoma: results of the pediatric intergroup liver tumor study (CCG 8881/POG 8945). Med Pediatr Oncol 1994, 23, 170 (Abstr 0-5).
24. von Schweinitz D, Bürger D, Bode U, et al. Results of the study HB-89 in the treatment of malignant epithelial liver tumors of childhood and concept for a new protocol HB-94. Klin Pädiatr 1994, 206, 282-288.
25. Archer D, Babyn P, Gilday D, Greenberg MA. Potentially misleading bone scan findings in patients with hepatoblastoma. Clin Nucl Med 1993, 18, 1026-1031.
26. Stevens MCG, Brandis M. Incidence and etiology of ifosfamide nephrotoxicity: report of a meeting held in Rhodes, Greece, October 3, 1991, sponsored by Asta Medica, Frankfurt, Germany. Med Pediatr Oncol 1993, 21, 640-644.
27. Kühl J-S, Tschöpe K, von Schweinitz D, Riehm HJ. Expression of mdrl/P-glycoprotein in children with advanced hepatoblastoma. Proc Am Ass Cancer Res 1994, 35, 208 (Abstr. 1241).
28. Kung FH, Pratt CB, Vega RA, et al. Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. Cancer 1993, 71, 1898-1903.
29. Lockwood L, Henley D, Giles GR, Lewis IJ, Bailey CL. Cisplatin-resistant metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplantation. Med Pediatr Oncol 1993, 21, 517-520.
30. Haas JE, Muczinsky KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989, 64, 1082-1095.
31. Conran RM, Hitchcock CL, Waclawiw MA, Stocker JT, Ishak KG. Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 1992, 12, 167-183.
32. Saxena R, Leake JL, Shafford EA, et al. Chemotherapy effects on hepatoblastoma. Am J Surg Pathol 1993, 17, 1266-1271.